January 2024 MHRA Safety Communications Summary The MHRA has published a summary of letters and notifications issued to healthcare professionals during January 2024 concerning medicines and medical devices. This update consolidates important safety information relevant to prescribers, dispensers, and clinical teams across all settings. What You Need to Know The January 2024 communications package includes […]
MHRA Alert – Valproate Safety Materials for Under-55s
New Safety Guidance on Valproate Use The MHRA has published new safety and educational materials for valproate-containing medicines to support regulatory measures protecting men and women under 55 years of age from serious harm. Key Points Valproate carries a significant risk of serious birth defects and developmental disorders if taken during pregnancy New safety materials […]
MHRA Alert – Fluoroquinolone Antibiotics: Restricted Prescribing Now in Effect
Key Update The MHRA has issued updated guidance on systemic fluoroquinolone antibiotics, effective immediately. These agents must now be prescribed only when other commonly recommended antibiotics are inappropriate. What Has Changed? Following a comprehensive safety review, fluoroquinolones are no longer considered first-line or routine options for bacterial infections. This restriction reflects the balance between their […]